PRN Meeting: November 11, 2020 Jointly provided by the Medical Society of the State of New York, at a Zoom webinar, 7:00 p.m. to 9:00 p.m (EST).

Target Audience:

Physicians, Nurse Practitioners, and Physician Assistants caring for people at risk for, or infected with HIV and/or viral hepatitis.

Course Director: James F. Braun, DO, President, Physicians' Research Network

Moderator: William M. Valenti, MD, Chair, Infectious Diseases Committee of the Medical Society of the State of New York

Guest Speakers and Presentations:

Multidimensional Challenge of COVID-19: Including COVID-19 and HIV

Rajesh T. Gandhi, MD

Professor of Medicine, Harvard Medical School
Director of HIV Clinical Services and Education
Clinical Research Site leader, AIDS Clinical Trials Group
Massachusetts General Hospital, Boston, MA

Rajesh T. Gandhi is the Director of HIV Clinical Services and Education at Massachusetts General Hospital and site leader of the MGH AIDS Clinical Research Site in the ACTG. Dr. Gandhi is a member of the NIH Covid-19 Treatment Guidelines Panel and the IDSA Covid-19 Treatment Guidelines Panel. He is also a scientific member of the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, and the IAS-USA Panel on Antiretroviral Drugs for Treatment and Prevention of HIV in Adults. Dr. Gandhi is a Deputy Editor of NEJM Journal Watch Infectious Diseases and NEJM Journal Watch HIV/AIDS.

Learning Objectives:

1. Describe the major clinical manifestations of COVID-19.
2. List considerations in treating a person with COVID-19.
3. Summarize current understanding of COVID-19 in people with HIV.

Controversies in Testosterone Treatment 2020 in Cisgender and Transgender Men

Todd T. Brown, MD, PhD

Professor of Medicine
Johns Hopkins Hospital
Baltimore, MD

Todd Brown is the primary endocrine consultant to the Johns Hopkins HIV Clinic. His research focuses on metabolic, endocrine, and skeletal abnormalities observed in HIV-infected patients.  He is the co-chair of the Executive Committee of the MACS WIHS Combined Cohort Study and has served in leadership positions for the ACTG.  He has mentored multiple trainees from across the country and around the world in the area of HIV Comorbidities and Aging. He has published widely on the topic of HIV and endocrine conditions and lectures internationally on this and other issues related to metabolic diseases in HIV.

Learning Objectives:

1. Understand the potential risks and benefits of testosterone treatment in the older cisgender male.
2. Be familiar with the findings of the T Trials and the clinical questions that still remain.
3. Understand what is known about the risks of testosterone for gender-affirming therapy in transgender men.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York (MSSNY) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement:

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity. Dr. Braun (Planner/Course Director) has no relevant financial relationships to disclose. Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose. Dr. Rajesh T. Gandhi (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Scientific advisory board with Merck. Dr. Gandhi will support his presentation and clinical recommendations with the best available evidence from the medical literature and will submit his slides in advance for adequate peer review. Dr. Todd T. Brown (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Consultant to Gilead, Janssen, Merck, Theatechnologies, and ViiV. Dr. Brown will support his presentation and clinical recommendations with the best available evidence from the medical literature and will submit his slides in advance for adequate peer review.

Financial Support:

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare